C12N15/863 - CPC Classification Index

ClassID:

109107 ⎘

C12N15/863 - CPC Classification

Classification description:

Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression; Vectors or expression systems specially adapted for eukaryotic hosts for animal cells; Viral vectors Poxviral vectors, e.g. entomopoxvirus

Recent Application in this class:

20240156940

REPLICATION-DEFICIENT MODIFIED VACCINIA ANKARA (MVA) EXPRESSING MARBURG VIRUS GLYCOPROTEIN (GP) AND MATRIX PROTEIN (VP40)

20220213161

MODIFIED INTERLEUKIN 12 AND USE THEREOF IN PREPARING DRUGS FOR TREATING TUMOURS

20220152190

Replication-deficient modified vaccinia Ankara (MVA) expressing glycoprotein (GP) and matrix protein (VP40)

20210338788

Compositions and methods for enhancing the stability of transgenes in poxviruses

20200061174

Compositions and methods for enhancing the stability of transgenes in poxviruses

20190117758

Replication-deficient modified vaccinia Ankara (MVA) expressing Ebola virus glycoprotein (GP) and matrix protein (VP40)

20190010200

Modified interleukin 12 and use thereof in preparing drugs for treating tumours

20180094050

Vaccines against HER3 antigens and methods of using the same

20180080048

Poxvirus-derived promoter, and vector comprising same

20170340721

Methods and compositions for enhancing immune responses

20130209513

Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains

20130136767

Compositions, methods and uses for poxvirus elements in vaccine constructs

20120183573

Intracellular viral vector delivery method employing iron ion/viral vector composite